3g Glycine, 60 Minutes Out: The Thermoregulatory Play Melatonin Cannot Match on the Night Shift

Sleep onset is a thermoregulatory event.

That sentence is the whole post. Everything below is the proof, the dose, and the timing.

When a healthy adult falls asleep at night, the trigger is not darkness, not melatonin, not fatigue. The trigger is a 0.3 to 0.5 degree Celsius drop in core body temperature driven by distal skin vasodilation. Blood shunts from the core to the hands and feet, heat radiates out, the hypothalamic set point falls, and the brain interprets the gradient as permission to disengage. Every other sleep signal, melatonin included, sits upstream of or parallel to this event. They bias the system. Temperature executes it.

This is why a hospital security supervisor clocking out at 07:00 and lying down at 08:00 has a biological problem no sleep hygiene checklist can solve. Adenosine has been accumulating for 16 to 20 hours. But cortisol is climbing on its natural waking ramp, core temperature is rising roughly 0.5 to 1.0 degrees Celsius above nocturnal nadir, and morning light on the commute home has already hit the intrinsically photosensitive retinal ganglion cells that drive SCN signaling. The worker is simultaneously exhausted and biologically scheduled to be awake. Sleep efficiency collapses even when total time in bed looks adequate on a wearable. Fragmented N3 sleep is the first casualty, which matters because N3 is where growth hormone pulses, glymphatic clearance accelerates, and autonomic recovery happens.

Glycine intervenes at the exact layer that matters.

The mechanism, in order of operation

Glycine is a non-essential amino acid that functions as an inhibitory neurotransmitter in the brainstem and spinal cord, and as a co-agonist at NMDA receptors in the suprachiasmatic nucleus. Oral glycine crosses the blood-brain barrier readily and binds SCN NMDA sites within roughly 30 to 60 minutes of a 3g dose.

Three things happen in sequence.

First, vasodilation. Bannai and Kawai (Frontiers in Neurology, 2012) demonstrated this directly. 3g oral glycine produced measurable cutaneous vasodilation at the hands and feet within the sleep-onset window, with a corresponding drop in core body temperature of approximately 0.2 to 0.4 degrees Celsius. This is not sedation. This is the same distal vasodilation cascade that precedes natural nighttime sleep onset, reproduced on demand. For a shift worker lying down when their body wants to be heating up for the day, this is the mechanism that matters. You are not sedating the brain. You are forcing the thermoregulatory step that normally opens the sleep gate.

Second, shortened slow-wave latency. Yamadera et al. (Sleep and Biological Rhythms, 2007) ran a placebo-controlled crossover in subjects with unsatisfactory sleep. 3g glycine 60 minutes pre-bed produced a significant reduction in Pittsburgh Sleep Quality Index scores, faster progression to slow-wave sleep on polysomnography, and improved subjective sleep quality the following day. No benzodiazepine pharmacology. No morning grogginess on cognitive batteries. The single most disqualifying side effect for anyone driving home from a 12-hour overnight is next-day sedation, and glycine does not produce it.

Third, next-day function after short sleep. Inagawa et al. (2006) tested 3g glycine in subjects under partial sleep deprivation, the exact population a rotating shift worker resembles every week, and measured a significant reduction in subjective fatigue and daytime sleepiness versus placebo. This is the study that earns glycine its spot in a shift worker's kit. The honest reality of overnight work is that sleep will sometimes be short. Inagawa's data says better-quality sleep in a compressed window preserves next-day performance better than longer fragmented sleep without it.

Summary: glycine does not make you tired. It tells your vasculature to behave as if it were midnight, which tells your brain the gate is open, which lets existing adenosine pressure finish the job.

Why this beats melatonin for the night shift

Melatonin is a phase-shifting hormone, not a sedative. Its dominant mechanism is entrainment of the SCN pacemaker. Timing of exogenous melatonin relative to the endogenous dim-light melatonin onset determines whether a dose advances or delays the circadian phase. Take it at the wrong clock position and it shifts the pacemaker the wrong direction.

For a permanent or rotating night shift worker, "the wrong clock position" is the default condition. Their DLMO is displaced, unstable, or inverted. Standard 07:00 or 08:00 melatonin dosing can re-entrain them toward a daytime-active rhythm they then have to fight again on their next overnight. The worker wakes after four hours with the pacemaker partially re-aligned to a schedule that does not match the next shift rotation. The result is a worker who feels worse after two weeks of melatonin than they did before.

Glycine does not engage the phase-shifting system at all. It acts on thermoregulation and sleep architecture without touching the SCN's timing signal. You can dose it on a 3-on, 3-off rotation. You can dose it only on overnights. You can dose it on days off for a nap. The intervention is agnostic to your circadian position because it is not trying to move your clock. It is trying to open the thermal gate your clock keeps shutting.

This is the category confusion that keeps well-intentioned shift workers stuck. Melatonin is a chronobiotic. Glycine is a sleep-onset facilitator. They are not interchangeable and they are not competitors. Sedating antihistamines and Z-drugs occupy a third category: they shorten latency at the cost of fragmenting slow-wave architecture, carrying anticholinergic load across consecutive shifts, or generating tolerance. For most rotating night workers, glycine is the correct primary tool, and the other categories are specialist levers reserved for specific problems.

Dose, timing, form

Three grams. Sixty minutes before the intended sleep window, not at lights-out. The vasodilatory effect needs runway.

Pharmaceutical-grade glycine powder dissolved in cold water, slightly sweet on the palate, no capsule lag. Capsules work but require swallowing nine to ten 300mg caps to hit the dose, which defeats the price point and delays absorption.

Not 1g. The published effect sizes in Yamadera, Bannai, and Inagawa are all at 3g. Lower doses do not reliably produce the vasodilation response Bannai measured. Not 5g either for this application. Diminishing returns and unnecessary osmotic load.

Stack and environment

• Magnesium glycinate, 300 to 400mg elemental, with the glycine dose. The glycinate form contributes additional glycine and the magnesium supports GABA tone.
• Bedroom at 65 to 67 degrees Fahrenheit. Glycine lowers core temperature. Ambient heat fights the mechanism.
• Blackout curtains plus sleep mask. Retinal photoreceptor signal is the one thing glycine cannot override.
• Orange or red tinted wraparound sunglasses on the commute home, before the parking lot. Morning light on the drive home does more damage to the next sleep block than most workers realize.
• Caffeine cutoff 8 to 10 hours before the pre-sleep dose, not before the start of shift. Caffeine half-life is 5 to 6 hours. A 03:00 coffee is still at 50 percent at 09:00.
• No alcohol as a sleep aid. It suppresses REM and fragments the slow-wave sleep that glycine is specifically recruiting.
• Foundational vitamins and minerals that chronic shift workers tend to run short on: methylfolate, methylcobalamin, magnesium, D3 paired with K2. Glycine is the pre-sleep lever that sits on top of that foundation.

The post-shift sequence

1. End shift. Orange-tinted glasses on before the parking lot.
2. Home within 30 minutes. Cold, dark room. Phone in another room or on grayscale.
3. 3g glycine in cold water 60 minutes before you want to be asleep.
4. Sleep block of 6 to 7.5 hours, protected from daylight and household noise.
5. On waking: direct sunlight within 10 minutes to anchor the shifted rhythm, protein-forward meal, train if training is programmed.

What the protocol is not

It is not a stimulant replacement. It does not fix shift work disorder. It does not compensate for chronic sleep debt of more than one or two cycles. It does not replace sleep, and it will not rescue a worker who is stacking alcohol, late heavy meals, and screen time in front of the sleep window.

It is a single-lever intervention at the thermoregulatory gate, and it is the correct first lever.

I built the Legacy In Motion protocol stack on this logic while running a 112 pound transformation from 308 to 196 as a day-shift hospital security supervisor: identify the rate-limiting physiological step, dose the specific molecule that acts there, verify against published effect sizes. Glycine at 3g sixty minutes out is the entry in the stack for anyone whose sleep window runs against their circadian temperature curve.

Yamadera's effect sizes are moderate, not miraculous. Bannai's mechanism is elegant, not marketable. Inagawa's fatigue data is useful, not sexy. Three moderate effects converging on the same outcome is what a usable protocol looks like. The dose is cheap, the side-effect profile is clean, and the mechanism does not fight the circadian system the way melatonin does when workers get the timing wrong.

Try it for seven consecutive post-shift sleeps. Measure PSQI at day zero and day seven. The data will do the talking.